Switch to:
More From Other Websites
Why is Celgene So Darn Expensive? Jun 30 2015
Citigroup Still Says Sell AbbVie Jun 30 2015
Is Celgene's Juno Deal a Boon or a Boondoggle? Jun 30 2015
Evercore ISI Analyst Breaks Down Amgen's IPR Against AbbVie's Humira Formulation Patent Jun 29 2015
Biotech Short-Sellers Prefer Amgen To Gilead Sciences Jun 27 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK